Natural killer cells and control of SIV infection
Natural killer cells and control of SIV infection
批准号:
8085795
负责人:
R. PAUL JOHNSON
金额:
$73.36万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-15 至 2014-05-31
关键词:
Acquired Immunodeficiency SyndromeAcuteAddressAnimalsAntigensAutologousBiological AssayCD4 Positive T LymphocytesCell physiologyCellsCharacteristicsContainmentDataDevelopmentDown-RegulationEthicsExhibitsFemaleGenitourinary systemGoalsHIVHIV InfectionsImmune responseInfectionLaboratoriesLigandsLongitudinal StudiesMHC Class I GenesMacacaMacaca mulattaMediatingMolecularMucous MembraneNatural Killer CellsOutcomePathway interactionsPatientsPlayPopulationRelative (related person)ReportingRoleSIVSamplingShapesSignal TransductionSpecificitySumTechniquesTissuesUp-RegulationVaginaViralViral ProteinsVirusVirus DiseasesVirus Replicationarmbasegastrointestinalkiller inhibitory receptormemory CD4 T lymphocytemucosal sitenonhuman primateperipheral bloodreceptorreproductiveresearch studyresponsetransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Innate immune responses, including natural killer (NK) cell responses, are the principal defense against viral infections prior to the development of adaptive immune responses and can play a critical role in determining the outcome of viral infection. Increasing evidence suggests that NK responses can play a significant role in control of HIV replication. However, many critical questions on the role of NK cells in the control of HIV/SIV replication remain unanswered, including the potential contribution of mucosal NK responses to virus containment. Although NK cells have been identified in both gastrointestinal and genitourinary mucosa, these cells have been relatively poorly characterized, and little is known about their role in normal hosts. Practical and ethical considerations are likely to significantly constrain efforts to elucidate the roles of mucosal NK cells in HIV-infected subjects and examination of the role of these responses in nonhuman primates is likely to offer the best opportunity to address these key questions. Recent data from our laboratory have demonstrated previously unrecognized populations of NK cells in gastrointestinal and genitourinary tissues in rhesus macaques and developed a new set of techniques to characterize NK cells in peripheral blood and mucosal tissues. Armed with these new assays and drawing on the complementary expertise of the Johnson and Haase laboratories, we propose a comprehensive set of experiments to analyze the role of NK cells in SIV-infected macaques. Specific aims include: 1. to examine the role of mucosal NK cells in modulating the course of SIV infection following vaginal challenge; 2. to examine the mechanism of recognition of SIV-infected CD4+ cells by NK cells; and 3. to carry out longitudinal studies of perturbations of KIR expression and function in NK cells from SIV-infected animals. Innate immune responses, including natural killer cells, are the first line of defense against viral infections such as HIV, and often play a key role in early containment and in shaping the immune responses that follow. Although a large number of studies suggest that natural killer cells help the body defend itself against HIV infection, almost nothing is known about natural killer cells in mucosal sites, one of the most important tissues in the body for transmission of HIV and development of AIDS. The goal of this proposal is to study the role of natural killer cells in nonhuman primates infected with simian immunodeficiency virus (SIV), with particular emphasis on studies of natural killer cells in the gut and female reproductive tract.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Annual Symposium on Nonhuman Primates
-
批准号:10676977
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2022
-
负责人:R. PAUL JOHNSON
-
依托单位:
Annual Symposium on Nonhuman Primates
-
批准号:10554035
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2022
-
负责人:R. PAUL JOHNSON
-
依托单位:
Exome screening and directed breeding of rhesus for human genetic disease models
-
批准号:9111085
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2015
-
负责人:R. PAUL JOHNSON
-
依托单位:
Exome screening and directed breeding of rhesus for human genetic disease models
-
批准号:8970022
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2015
-
负责人:R. PAUL JOHNSON
-
依托单位:
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES
-
批准号:8357947
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION
-
批准号:8357913
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS
-
批准号:8357919
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
Immunology
-
批准号:8198155
-
项目类别:
-
资助金额:$36.47万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection
-
批准号:8198148
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION
-
批准号:8357948
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES
-
批准号:8172859
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Construction of a Dual Function Primate Facility: ABSL3 and Transplant Medicine
-
批准号:7877509
-
项目类别:
-
资助金额:$1486.82万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS
-
批准号:8172823
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8292099
-
项目类别:
-
资助金额:$75.6万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION
-
批准号:8172817
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
CD8+ T CELLS AND PROTECTION AGAINST VAGINAL CHALLENGE INDUCED BY SIVMAC239DELTA3
-
批准号:8172858
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8467672
-
项目类别:
-
资助金额:$71.07万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Mechanisms of protective immunity induced by live attenuated SIV vaccines
-
批准号:8064463
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:7988488
-
项目类别:
-
资助金额:$79.47万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION
-
批准号:8172860
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
海外基金